Improving hepatitis A vaccination rates in hospitalised patients with cirrhosis: insights and lessons learnt

BMJ Open Quality

article

Ryan Jean Kronen¹  Madeleine Haff²  Vilas Patwardhan³  Mary LaSalvia⁴ 

[1] Department of Medicine , University of Washington;Division of Gastroenterology, Internal Medicine , Boston University;Division of Gastroenterology and Hepatology, Internal Medicine , Beth Israel Deaconess Medical Center;Division of Infectious Diseases, Internal Medicine , Beth Israel Deaconess Medical Center

关键词: healthcare quality improvement;    quality improvement;    decision support;    clinical;    checklists;   

DOI  :  10.1136/bmjoq-2021-001723

学科分类：药学

来源: BMJ Publishing Group

【 摘 要 】

Vaccine uptake has been a long-standingchallenge in public health spanning a widearray of patients and diseases,1 but the needto identify and address barriers to vaccineutilisation has never been more apparent forour generation than during the COVID-19era. Even when effective vaccines are available, challenges surrounding implementation can lead to failure of disease controland eradication. Hepatitis vaccination servesas a telling example of this implementationgap and presents an important opportunityfor learning. In patients with cirrhosis, theCenters for Disease Control and Preventionrecommends hepatitis A and B vaccination,since hepatitis infection in those with liverdisease is associated with increased morbidityand mortality.2 Despite this recommendation, hepatitis vaccination rates in this vulnerable population remain low.

【 授权许可】

CC BY-NC|CC BY|CC BY-NC-ND